Anticonvulsant Actions of Anticholinergic Drugs in Soman Poisoning

Epilepsia

Volumn 32, Issue 5, 1991, Pages 604-615

  Capacio, Benedict R ^a   Shih, Tsung‐Ming ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Anticholinergic drugs; Anticonvulsants; Anti muscarinic compounds; Convulsions; Organophosphorus compounds; Secretions; Soman

Indexed keywords

APROFENE; ATROPINE; AZAPROPHEN; BENACTYZINE; BENZATROPINE; BIPERIDEN; CHOLINESTERASE; SCOPOLAMINE; SOMAN; TRIHEXYPHENIDYL;

AGED; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; ATROPINE; ATROPINE DERIVATIVES; CONVULSIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOLECULAR STRUCTURE; PARASYMPATHOLYTICS; RATS; RATS, INBRED STRAINS; SCOPOLAMINE; SCOPOLAMINE DERIVATIVES; SECRETORY RATE; SOMAN;

EID: 0026008682     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1991.tb04699.x     Document Type: Article

References (75)

1. Selective blockade of NMDA‐activated channel currents may be implicated in learning deficits caused by lead
2. pH and drug action
3. Reciprocal effects of alpha‐ and gamma‐motoneurons of drugs influencing monoaminergic and cholinergic transmission
4. Drugs and the treatment of psychiatric disorders
5. Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists
6. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2‐trimeth‐ylpropyl methylphosphonofluoridate
7. Drugs for Parkinson's disease, spasticity, and acute muscle spasms
8. Muscarinic receptor subclasses
9. The treatment of soman poisoning and its perspectives
10. MK‐801 protects against seizures induced by the cholinesterase inhibitor soman
11. Binding of soman antidotes to acetylcholine receptors
12. The relative selectivity of anticholinergic drugs for the Ml and M2 muscarinic receptor subtypes
13. Anticonvulsant effects of anticholinergics in soman poisoning
14. 6‐Methyl‐6‐azabicy‐clo[3.2.1]octan‐3 alpha‐ol 2,2 diphenylpropionate (Aza‐prophen), a highly potent antimuscarinic agent
15. Actions of (‐)scopol‐amine and atropine on NMDA receptors: implications on memory and learning
16. Restoration of shock‐suppressed behavior by treatment with (+)‐5‐methy 1–10,11‐dihydro‐5H‐diben‐zo[a,d]cyclohepten‐5,10‐imine (MK801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
17. Contemporary drug abuse
18. The protection of primates against soman poisoning by pretreatment with pyridostigmine
19. Progress in medical defense against nerve agents
20. Cholinergic‐anticholinergic antagonism in parkinsonism
21. Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate
22. Muscarinic Ml, M2 receptor binding. Relationship with functional efficacy
23. The protection of animals against organophosphate poisoning by pretreatment with a carbamate
24. Dual mechanism of the antidotal action of atropine‐like drugs in poisoning by organophosphorus anticholinesterases
25. Pirenzepine distinguishes between different subclasses of muscarinic receptors
26. Selective memory impairment by phencyclidine in rats
27. Hypnotics and sedatives
28. The binding of antagonists to brain muscarinic receptors
29. Atropine, scopolamine, and ditran: comparative pharmacology and antagonists in man
30. Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization
31. Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model
32. Toxicity and tissue cholinesterase activity following soman, atropine and HI‐6 treatment
33. Treatment of poisoning by soman
34. Histological and histochemical changes in the central nervous system of the rat poisoned with an irreversible anticholinesterase compound
35. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality
36. Effect of diazepam upon soman‐induced seizure activity and convulsions
37. Effect of benzodiazepine derivatives on soman‐induced seizure activity and convulsions in the monkey
38. 3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain
39. Long‐lasting facilitation of excitatory postsynaptic potentials in the rat hippocampus by acetylcholine
40. Atropine and/or diazepam therapy protects against soman‐induced neural and cardiac pathology
41. Direct microinjection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology
42. Pathology of nerve agents: perspectives on medical management
43. NMDA receptor antagonists can enhance or impair learning performance in animals
44. Selective impairment of learning and blockade of long‐term potentiation by an N‐methyl‐D‐aspartate antagonist, AP5
45. Excitotoxicity and N‐methyl‐D‐aspartate receptors
46. Excitotoxic mechanisms of epileptic brain damage
47. Seizure‐related brain damage induced by cholinergic agents
48. Anti‐parkinsonian agents are phencyclidine agonists and N‐methyl‐aspartate antagonists
49. Soman neurotoxicity
50. Procyclidine protects against soman neurotoxicity, even when administered after onset of convulsions
51. Effects of diazepam on epileptiform patterns of bioelectrical activity of the rabbit's brain induced by fluostigmine
52. Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain
53. Anticonvulsant effects of diazepam and MK‐801 in soman poisoning
54. Relationship between soman‐induced lethality and depression of tissue cholinesterase activity
55. Relationship between soman‐induced elevation of brain regional acetylcholine concentrations and lethality
56. Evaluation of the anticonvulsant effects of diazepam and MK‐801 in soman poisoning
57. Cholinergic effects of HI‐6 in soman poisoning
58. Effects of antiparkinsonian drugs on muscarinic receptor binding in rat brain, heart and lung
59. Interaction of psychotropic drugs with brain muscarinic cholinocep‐tors: similarities of biperiden with pirenzepine in receptor binding properties
60. Dopamine‐acetylcholine interaction in the basal ganglia
61. Anticholinesterase agents
62. Organophosphorus poisoning
63. Changes in extracellular amino acids during soman‐ and kainic acid‐induced seizures
64. 3H]‐pirenzepine
65. 3H]‐Pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex
66. 3H]‐pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes
67. Atropine, scopolamine, and related antimuscarinic drugs
68. Comparison of in vitro actions with behavioral effects of antimuscarinic agents
69. Effects of MK‐801 on memory retention in the rat
70. Muscarinic binding in rat brain